• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comprehensive overview of COVID-19 based on current evidence.基于现有证据的 COVID-19 综合概述。
Dermatol Ther. 2020 Sep;33(5):e13525. doi: 10.1111/dth.13525. Epub 2020 May 22.
2
Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.概述:严重急性呼吸系统综合征的历史和儿科视角:新型还是类似 SARS。
Pediatr Pulmonol. 2020 Jul;55(7):1584-1591. doi: 10.1002/ppul.24810. Epub 2020 Jun 1.
3
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病(COVID-19)疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
4
Testing the identification effectiveness of an unknown outbreak of the Infectious Diseases Seeker (IDS) using and comparing the novel coronavirus disease (COVID-19) outbreak with the past SARS and MERS epidemics.利用新型冠状病毒病(COVID-19)暴发与过去的 SARS 和 MERS 疫情进行比较,测试传染病探寻者(IDS)未知暴发的识别效果。
J Infect Public Health. 2021 Jan;14(1):123-130. doi: 10.1016/j.jiph.2020.11.014. Epub 2020 Dec 9.
5
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.新型严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)的爆发:当前全球状况综述。
J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4.
6
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
7
Coronavirus Disease 2019: Coronaviruses and Blood Safety.2019 年冠状病毒病:冠状病毒与血液安全。
Transfus Med Rev. 2020 Apr;34(2):75-80. doi: 10.1016/j.tmrv.2020.02.003. Epub 2020 Feb 21.
8
Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us.新兴人类冠状病毒感染(SARS、MERS 和 COVID-19):它们将把我们带向何方。
Int Rev Immunol. 2021;40(1-2):5-53. doi: 10.1080/08830185.2020.1800688. Epub 2020 Aug 3.
9
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)和 2019 年冠状病毒病(COVID-19):疫情和挑战。
Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924. Epub 2020 Feb 17.
10
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.SARS-CoV-2 感染期间免疫反应概述:从过去中吸取的教训。
Front Immunol. 2020 Aug 7;11:1949. doi: 10.3389/fimmu.2020.01949. eCollection 2020.

引用本文的文献

1
An online questionnaire survey on the sexual function of Chinese male adults in the COVID-19 pandemic with loosened controls.一项关于新冠疫情防控措施放松后中国成年男性性功能的在线问卷调查。
Prev Med Rep. 2023 Oct 7;36:102464. doi: 10.1016/j.pmedr.2023.102464. eCollection 2023 Dec.
2
SARS-COV-2 protein NSP9 promotes cytokine production by targeting TBK1.SARS-CoV-2 蛋白 NSP9 通过靶向 TBK1 促进细胞因子产生。
Front Immunol. 2023 Oct 2;14:1211816. doi: 10.3389/fimmu.2023.1211816. eCollection 2023.
3
The psychological stress response of COVID-19 to medical staff and prevention: A large sample study from China.新型冠状病毒肺炎对医护人员的心理应激反应及预防:一项来自中国的大样本研究。
Front Psychol. 2023 Mar 22;14:1125847. doi: 10.3389/fpsyg.2023.1125847. eCollection 2023.
4
Impacts of COVID-19 on Patients With Common Surgical Emergencies at the King Fahad Specialist Hospital in Buraidah, Saudi Arabia.新型冠状病毒肺炎对沙特阿拉伯布赖代法赫德国王专科医院常见外科急症患者的影响。
Cureus. 2022 Nov 24;14(11):e31868. doi: 10.7759/cureus.31868. eCollection 2022 Nov.
5
Suicidal ideation in the general population in China after the COVID-19 pandemic was initially controlled.中国新冠肺炎疫情得到初步控制后普通人群中的自杀意念。
J Affect Disord. 2023 Feb 15;323:834-840. doi: 10.1016/j.jad.2022.12.036. Epub 2022 Dec 16.
6
Influence of public health and infection control interventions during the severe acute respiratory syndrome coronavirus 2 pandemic on the in-hospital epidemiology of pathogens: in hospital versus community circulating pathogens.严重急性呼吸综合征冠状病毒2大流行期间公共卫生和感染控制干预措施对医院内病原体流行病学的影响:医院内病原体与社区传播病原体的比较
Antimicrob Resist Infect Control. 2022 Nov 11;11(1):140. doi: 10.1186/s13756-022-01182-z.
7
Hereditary Thrombophilia in the Era of COVID-19.新冠疫情时代的遗传性血栓形成倾向
Healthcare (Basel). 2022 May 27;10(6):993. doi: 10.3390/healthcare10060993.
8
Towards antiviral polymer composites to combat COVID-19 transmission.对抗新冠病毒传播的抗病毒聚合物复合材料
Nano Sel. 2021 Nov;2(11):2061-2071. doi: 10.1002/nano.202100078. Epub 2021 May 4.
9
Effects of WeChat-based psychological interventions on the mental health of patients with suspected new coronavirus pneumonia: A pilot study.基于微信的心理干预对疑似新型冠状病毒肺炎患者心理健康的影响:一项初步研究。
Jpn J Nurs Sci. 2021 Oct;18(4):e12429. doi: 10.1111/jjns.12429. Epub 2021 May 17.
10
Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel monoclonal antibodies for the treatment of COVID-19 clinical cases.细胞因子风暴靶向抗体的使用和风险相关问题的观点,以及针对 COVID-19 临床病例治疗开发新型单克隆抗体所面临的挑战。
Hum Vaccin Immunother. 2021 Sep 2;17(9):2824-2840. doi: 10.1080/21645515.2021.1908060. Epub 2021 May 11.

本文引用的文献

1
Single-cell analysis of angiotensin-converting enzyme II expression in human kidneys and bladders reveals a potential route of 2019 novel coronavirus infection.单细胞分析人类肾脏和膀胱中血管紧张素转化酶 2 的表达,揭示了 2019 年新型冠状病毒感染的潜在途径。
Chin Med J (Engl). 2021 Apr 20;134(8):935-943. doi: 10.1097/CM9.0000000000001439.
2
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.2019 年新型冠状病毒刺突蛋白在预融合构象的冷冻电镜结构
Science. 2020 Mar 13;367(6483):1260-1263. doi: 10.1126/science.abb2507. Epub 2020 Feb 19.
3
Three Emerging Coronaviruses in Two Decades.二十年间出现的三种新型冠状病毒。
Am J Clin Pathol. 2020 Mar 9;153(4):420-421. doi: 10.1093/ajcp/aqaa029.
4
The reproductive number of COVID-19 is higher compared to SARS coronavirus.与严重急性呼吸综合征冠状病毒相比,新型冠状病毒肺炎的繁殖数更高。
J Travel Med. 2020 Mar 13;27(2). doi: 10.1093/jtm/taaa021.
5
Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections.新型冠状病毒(2019-nCoV)感染孕妇的母婴潜在结局:来自 SARS、MERS 和其他人类冠状病毒感染的教训。
Viruses. 2020 Feb 10;12(2):194. doi: 10.3390/v12020194.
6
Pre- and Posttreatment Chest CT Findings: 2019 Novel Coronavirus (2019-nCoV) Pneumonia.治疗前和治疗后胸部CT表现:2019新型冠状病毒(2019-nCoV)肺炎
Radiology. 2020 Apr;295(1):21. doi: 10.1148/radiol.2020200323. Epub 2020 Feb 12.
7
Chest CT for Typical Coronavirus Disease 2019 (COVID-19) Pneumonia: Relationship to Negative RT-PCR Testing.胸部 CT 与典型 2019 冠状病毒病(COVID-19)肺炎:与阴性 RT-PCR 检测的关系。
Radiology. 2020 Aug;296(2):E41-E45. doi: 10.1148/radiol.2020200343. Epub 2020 Feb 12.
8
The progress of 2019 novel coronavirus event in China.2019新型冠状病毒事件在中国的进展。
J Med Virol. 2020 May;92(5):468-472. doi: 10.1002/jmv.25705. Epub 2020 Feb 26.
9
The global spread of 2019-nCoV: a molecular evolutionary analysis.2019-nCoV 在全球的传播:分子进化分析。
Pathog Glob Health. 2020 Mar;114(2):64-67. doi: 10.1080/20477724.2020.1725339. Epub 2020 Feb 12.
10
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.从 2019 年新冠病毒感染患者中提取的临床和生化指标与病毒载量和肺部损伤有关。
Sci China Life Sci. 2020 Mar;63(3):364-374. doi: 10.1007/s11427-020-1643-8. Epub 2020 Feb 9.

基于现有证据的 COVID-19 综合概述。

Comprehensive overview of COVID-19 based on current evidence.

机构信息

China Pharmaceutical University & Jiangsu Key Laboratory of Oncogenesis and Intervention, Nanjing, Jiangsu, China.

Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

出版信息

Dermatol Ther. 2020 Sep;33(5):e13525. doi: 10.1111/dth.13525. Epub 2020 May 22.

DOI:10.1111/dth.13525
PMID:32378801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7267400/
Abstract

In December 2019, twenty-seven pneumonia patients with unknown causes originated in South China seafood market in Wuhan. The virus infection spread rapidly and swept through China in less than a month. Subsequently, the virus was proven a novel coronavirus and named SARS-CoV-2. The outbreak of novel coronavirus has been determined as a Public Health Emergency of International Concern (PHEIC) by WHO on January 31, 2020. Similar to other coronaviruses like the Middle East Respiratory Syndrome (MERS) CoV and Severe Acute Respiratory Syndrome (SARS) CoV, the novel coronavirus was reported to spread via respiratory droplets and close contact from human to human, which means the virus is highly infectious and dangerous. Unfortunately, till now the virus has spread to over 200 countries/territories/areas around the world and the Coronavirus Disease 2019 (COVID-19) outbreak is continuing to grow. Currently, information sharing and transparency are essential for risk assessment and epidemic control in all endemic areas. In this article, we compared SARS-CoV-2 with SARS-CoV and influenza virus, discussed current researching progress of COVID-19, including clinical characteristics, pathological changes, treatment measures, and so on.

摘要

2019 年 12 月,27 例病因不明的肺炎患者起源于武汉华南海鲜市场。病毒感染迅速蔓延,不到一个月就席卷中国。随后,该病毒被证明是一种新型冠状病毒,并被世界卫生组织(WHO)命名为 SARS-CoV-2。2020 年 1 月 31 日,世界卫生组织将新型冠状病毒疫情确定为国际关注的突发公共卫生事件(PHEIC)。与其他冠状病毒(如中东呼吸综合征(MERS)CoV 和严重急性呼吸综合征(SARS)CoV)类似,新型冠状病毒据报道通过呼吸道飞沫和人与人之间的密切接触传播,这意味着该病毒具有高度传染性和危险性。不幸的是,截至目前,该病毒已传播到全球 200 多个国家/地区,2019 年冠状病毒病(COVID-19)疫情仍在持续蔓延。目前,信息共享和透明度对于所有流行地区的风险评估和疫情控制至关重要。在本文中,我们将 SARS-CoV-2 与 SARS-CoV 和流感病毒进行了比较,讨论了 COVID-19 的当前研究进展,包括临床特征、病理变化、治疗措施等。